We further investigated the M2-like macrophages in ovarian tumor by IHC analysis for ARG1, a hallmark of alternatively activated macrophages; there was a significant decrease after ABBV-075 and AVA treatment (p < 0.001) (Fig. 1I, J). This evidence concerns the gene ARG1 and ovarian neoplasm.